Clinical trials
Phase 4 Dementia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 6 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Unknown status | 10 |
| Recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 3 |
| Enrolling by invitation | 3 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| VA Office of Research and Development | 4 |
| Mayo Clinic | 3 |
| Novartis | 3 |
| Sunnybrook Health Sciences Centre | 2 |
| Sykehuset Innlandet HF | 2 |
| Abarbanel Mental Health Center | 1 |
| Ariel Gildengers, MD | 1 |
| Avanir Pharmaceuticals | 1 |
| Baylor Research Institute | 1 |
| Centre for Addiction and Mental Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 73 |
| Alzheimer Disease | 31 |
| Cognitive Dysfunction | 18 |
| Stroke | 7 |
| Psychomotor Agitation | 6 |
| Frontotemporal Dementia | 5 |
| Lewy Body Disease | 5 |
| Lethargy | 4 |
| Parkinson Disease | 4 |
| Cardiovascular Diseases | 3 |
Trials
Showing 51 to 73 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.